According to the Zhitong Finance App, Lee's Pharmaceutical Company (00950.HK) issued an announcement. On November 18, 2026 (after the transaction period), the buyer (an indirect wholly-owned subsidiary of the Company) placed a purchase order with the seller to purchase the equipment, at a maximum cost of US$76.684 million (equivalent to approximately HK$598.14 million).

Zhitongcaijing · 1d ago
According to the Zhitong Finance App, Lee's Pharmaceutical Company (00950.HK) issued an announcement. On November 18, 2026 (after the transaction period), the buyer (an indirect wholly-owned subsidiary of the Company) placed a purchase order with the seller to purchase the equipment, at a maximum cost of US$76.684 million (equivalent to approximately HK$598.14 million).